In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Flexion Therapeutics, Inc.. Trade Record

NASDAQ:FLXN Flexion Therapeutics, Inc. stock gains 8.46% Exit May 28, 2019 a Trade Record by priceseries

Trade Chart
Trade Chart FLXN May 9, 2019, priceSeries
About Flexion Therapeutics, Inc.

Flexion Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It lead product candidate includes Zilretta, a late-stage, intra-articular, extended-release investigational steroid treatment that has completed Phase 3 clinical trials for IA therapy for patients with moderate and severe osteoarthritis pain. The company was founded in 2007 and is headquartered in Burlington, Massachusetts.

Trade Information
Trade Type
LONG
ReliabilityScore™
98.70
Entry Date
May 9, 2019
Entry Price
11.55
Sell Date
May 28, 2019
Sell Price
12.53
Net Gain
8.46%
Hold Time
12 Trading Days